CEPIvaccines Profile Banner
CEPI Profile
CEPI

@CEPIvaccines

Followers
44K
Following
8K
Media
5K
Statuses
13K

Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world. #100DaysMission

Global
Joined October 2016
Don't wanna be here? Send us removal request.
@CEPIvaccines
CEPI
10 months
Over 8 million people. That is the number of people who might be alive today if the international community had accomplished the 100 Days Mission to develop safe and effective new vaccines against SARS-CoV-2 in three months. 👉. @imperialcollege
19
16
35
@CEPIvaccines
CEPI
2 days
The #100DaysMission's success relies on establishing an enabling regulatory environment. One that can go even faster than the COVID response, whilst maintaining appropriate levels of regulatory oversight. CEPI experts describe how to achieve this ⬇️
Tweet card summary image
linkedin.com
Authored by Adam Hacker, Head of Regulatory Affairs and Quality, CEPI, and Meenu Batolar, Regulatory Affairs Asia Pacific Lead, CEPI In a rural Indian community, a mysterious disease has emerged....
0
1
4
@grok
Grok
3 days
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
992
3K
11K
@CEPIvaccines
CEPI
3 days
Did you know #AI is already helping the world get ahead of the next pandemic threat? This isn’t about the future, it’s happening now. Discover how CEPI-backed scientists are applying AI to help design better outbreak vaccines faster than ever ⬇️
Tweet card summary image
cepi.net
1
0
5
@CEPIvaccines
CEPI
6 days
Enable was first launched by CEPI and partners in 2019. Over 23,000 participants participated in the research across Benin, Guinea, Liberia, Nigeria and Sierra Leone, making it the largest-ever Lassa fever research study. (4/4).
0
0
2
@CEPIvaccines
CEPI
6 days
Scientists are also looking at how often people may be co-infected with Lassa fever and malaria since co-infections may complicate the clinical course of each disease. (3/4).
1
0
3
@CEPIvaccines
CEPI
6 days
Enable 1.5 aims to improve our understanding on how commonly Lassa fever occurs, how rates of infection and symptoms vary across selected locations, ages, sex and previous exposure to the virus, and the extent of post-infection symptoms like hearing loss (2/4).
1
0
3
@CEPIvaccines
CEPI
6 days
💡Enable 1.5 is a pioneering CEPI-supported study aiming to advance our understanding of Lassa fever virus and help inform Lassa vaccine development efforts. Read the study protocol, now published in @bmj_latest Public Health: 📸@NCDCgov
Tweet media one
Tweet media two
1
9
22
@CEPIvaccines
CEPI
7 days
CEPI has committed up to US$100 million to advance multiple Chikungunya vaccine candidates, one of which was the first-ever to receive FDA approval. Now, we're working to expand global access to this vaccine 💉. Learn more about #chikungunya ⬇️
Tweet card summary image
cepi.net
CEPI is advancing Chikungunya vaccine candidates through late-stage trials, focusing on expanding access to vulnerable populations in endemic
0
0
0
@CEPIvaccines
CEPI
7 days
Virus evolution, globalisation, vector adaptation, and climate change could further the spread of chikungunya, amplifying its already substantial global public health and economic consequences.
1
0
1
@CEPIvaccines
CEPI
7 days
Chikungunya was first identified in Tanzania in 1952 and has since become widely distributed across the globe. Millions of people have been affected by this disease and, today, over a billion people live in areas where chikungunya is endemic 🌎.
1
0
1
@CEPIvaccines
CEPI
7 days
The term chikungunya is derived from Kimakonde, a language spoken in Tanzania, and means “to become contorted” – a description of the joint pain that is commonly associated with infection.
1
0
0
@CEPIvaccines
CEPI
7 days
#Chikungunya is a mosquito-borne disease belonging to the togavirus viral family🦠. It is spread to humans through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus🦟
10
3
8
@CEPIvaccines
CEPI
8 days
📣 Korea's Disease Control and Prevention Agency and @IVIHeadquarters are joining our Centralised Labs Network, the world's largest group of laboratories working to standardise the assessment of new infectious disease vaccines 🇰🇷.
Tweet media one
0
1
3
@CEPIvaccines
CEPI
9 days
RT @GHTCoalition: Scientists have launched the first-ever adjuvant library, substances that boost vaccines' ability to create immunity. The….
0
1
0
@CEPIvaccines
CEPI
9 days
RT @CEPIvaccines: In late 2024, Marburg virus hit Rwanda for the first time. A new NPJ Vaccines article details how CEPI and partners hel….
Tweet card summary image
link.springer.com
npj Vaccines - How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak
0
8
0
@CEPIvaccines
CEPI
10 days
For more on the real-world life-saving impact of this and many other aspects of CEPI’s 100 Days Mission readiness work, go to our Impact page and read our Innovations for Impact series.
Tweet card summary image
cepi.net
CEPI supports more than 150 active R&D and manufacturing projects in over 50 countries around the world, building critical capabilities for the 100
0
0
0
@CEPIvaccines
CEPI
10 days
. and describe how other countries can learn from it to ramp up outbreak preparedness.
1
0
0
@CEPIvaccines
CEPI
10 days
In the paper, CEPI’s @DrRHatchett and Dr Nicole Lurie and co-authors from @RwandaHealth, @RBCRwanda, @IQVIA and @sabinvaccine detail the #100DaysMission readiness work that fed into this unprecedented and highly effective response. .
1
0
0
@CEPIvaccines
CEPI
10 days
In late 2024, Marburg virus hit Rwanda for the first time. A new NPJ Vaccines article details how CEPI and partners helped to quickly end the outbreak, with a Marburg vaccine deployed in a clinical trial just 10 days after the outbreak was declared ⬇️
Tweet card summary image
link.springer.com
npj Vaccines - How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak
2
8
13
@CEPIvaccines
CEPI
14 days
📣We’re launching the world's first library of adjuvants that can be ‘taken off the shelf’ and used to develop new epidemic and pandemic vaccines. Hosted by @MHRAgovuk, the $2.5m project will help developers select the best vaccine-adjuvant combinations:
Tweet media one
0
6
13